Heres what you need to know: Mechanism: Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) through beta-3 adrenergic receptor modulation and direct adipocyte interaction Primary Benefit: Enhanced fat metabolism and body composition improvement without affecting blood sugar or insulin sensitivity Administration: Subcutaneous injection or oral administration, typically daily Typical Dosing: 250-500 mcg daily via injection, or higher doses (1-2 mg) orally, administered in morning on empty stomach Results Timeline: Initial metabolic changes within 2-4 weeks, visible body composition changes in 8-12 weeks Best For: Individuals seeking metabolic support, stubborn fat reduction, and body recomposition without growth hormone effects Safety Profile: Clinical trials with over 900 participants demonstrated excellent tolerability with no serious adverse events Comparison: More selective than full-length growth hormone, targeting only fat metabolism without affecting glucose regulation or IGF-1 levels The following guide provides complete details on AOD-9604 s metabolic support process, from molecular mechanisms to practical protocols
calculated from McKesson Canada (Accessed February 17, 2022) Coverage is subject to drug price limits set by PharmaCare and to the patients PharmaCare plan rules and deductibles
These findings bring closer their usage in human clinical trials
That said, peptides, like anything else, need a consultation with a healthcare professional to decide if they're right for you and your goal
This compounded medication is not affiliated with or endorsed by Eli Lilly and is not intended as a substitute for FDA-approved products
